1: De J, Lu Y, Ling L, Peng N, Zhong Y. Essential Oil Composition and Bioactivities of Waldheimia glabra (Asteraceae) from Qinghai-Tibet Plateau. Molecules. 2017 Mar 13;22(3). pii: E460. doi: 10.3390/molecules22030460. PubMed PMID: 28335395.
2: Glaser J, Schultheis M, Moll H, Hazra B, Holzgrabe U. Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative. Molecules. 2015 Apr 1;20(4):5740-53. doi: 10.3390/molecules20045740. PubMed PMID: 25834987.
3: Flamini G, Cioni PL, Maccioni S, Baldini R. Essential oil composition and in vivo volatiles emission by different parts of Coleostephus myconis capitula. Nat Prod Commun. 2010 Aug;5(8):1321-4. PubMed PMID: 20839645.
4: Mathela CS, Padalia RC, Chanotiya CS. Kanokonyl acetate-rich Indian valerian from northwestern Himalaya. Nat Prod Commun. 2009 Sep;4(9):1253-6. PubMed PMID: 19831039.
5: Qi HY, Wei XN, Shi YP. Sesquiterpenoids from Valeriana tangutica. J Asian Nat Prod Res. 2009;11(1):33-7. doi: 10.1080/10286020802435778. PubMed PMID: 19177234.
6: Tanaka K, Komatsu K. Comparative study on volatile components of Nardostachys rhizome. J Nat Med. 2008 Jan;62(1):112-6. doi: 10.1007/s11418-007-0199-7. Epub 2007 Oct 6. PubMed PMID: 18404355.
7: Mathela CS, Chanotiya CS, Sammal SS, Pant AK, Pandey S. Compositional diversity of terpenoids in the Himalayan Valeriana genera. Chem Biodivers. 2005 Sep;2(9):1174-82. PubMed PMID: 17193199.
8: Torres-Valencia JM, Meléndez-Rodríguez M, Alvarez-García R, Cerda-García-Rojas CM, Joseph-Nathan P. DFT and NMR parameterized conformation of valeranone. Magn Reson Chem. 2004 Oct;42(10):898-902. PubMed PMID: 15366065.
9: Letchamo W, Ward W, Heard B, Heard D. Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. J Agric Food Chem. 2004 Jun 16;52(12):3915-9. PubMed PMID: 15186117.
10: Hazelhoff B, Malingré TM, Meijer DK. Antispasmodic effects of valeriana compounds: an in-vivo and in-vitro study on the guinea-pig ileum. Arch Int Pharmacodyn Ther. 1982 Jun;257(2):274-87. PubMed PMID: 7114974.
11: Rücker G, Tautges J, Sieck A, Wenzl H, Graf E. [Isolation and pharmacodynamic activity of the sesquiterpene valeranone from Nardostachys jatamansi DC]. Arzneimittelforschung. 1978;28(1):7-13. German. PubMed PMID: 580202.
12: Gupta PD, Virmani V. Clinical trial of jatamansone (syn: Valeranone) in hyperkinetic behaviour disorders. Neurol India. 1968 Oct-Dec;16(4):168-73. PubMed PMID: 4886500.
13: Hikino H, Takeshita Y, Hikino Y, Takemoto T. [Conformation of valeranone and derivatives]. Yakugaku Zasshi. 1967 Sep;87(9):1035-9. Japanese. PubMed PMID: 5627422.
14: Wenkert E, Berges DA. The stereospecific introduction of a vicinally functionalized angular methyl group. A synthesis of l-valeranone. J Am Chem Soc. 1967 May 10;89(10):2507-9. PubMed PMID: 6042758.
15: Hikino H, Hikino Y, Takeshita Y, Meguro K, Takemoto T. Structure and absolute configuration of valeranone. Chem Pharm Bull (Tokyo). 1965 Dec;13(12):1408-16. PubMed PMID: 5866238.
16: Hikino H, Takeshita Y, Hikino Y, Takemoto T. Conformation of valeranone and derivatives. Chem Pharm Bull (Tokyo). 1965 May;13(5):626-8. PubMed PMID: 5867724.
17: HIKINO H, HIKINO Y, TAKESHITA Y, MEGURO K, TAKEMOTO T. STRUCTURE OF VALERANONE. Chem Pharm Bull (Tokyo). 1963 Sep;11:1207-10. PubMed PMID: 14068747.